These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1823870)

  • 61. Plasma tenoxicam concentrations after single and multiple oral doses.
    Crevoisier C; Heizmann P; Forgo I; Dubach UC
    Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.
    Hildebrand M; Staks T; Nieuweboer B
    Eur J Clin Pharmacol; 1990; 39(2):149-53. PubMed ID: 2253664
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Photobinding of Triflusal to Human Serum Albumin Investigated by Fluorescence, Proteomic Analysis, and Computational Studies.
    Molins-Molina O; Pérez-Ruiz R; Lence E; González-Bello C; Miranda MA; Jiménez MC
    Front Pharmacol; 2019; 10():1028. PubMed ID: 31616294
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Photosensitivity associated with treatment with triflusal.
    Nagore E; Pérez-Ferriols A; Sánchez-Motilla JM; Serrano G; Aliaga A
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):219-21. PubMed ID: 11032071
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects.
    Barzaghi N; Leone L; Monteleone M; Tomasini G; Perucca E
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):293-8. PubMed ID: 2633923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects.
    Lacroix C; Hoang TP; Nouveau J; Guyonnaud C; Laine G; Duwoos H; Lafont O
    Eur J Clin Pharmacol; 1989; 36(4):395-400. PubMed ID: 2737233
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New resorbable polymeric systems with antithrombogenic activity.
    Rodríguez G; Gallardo A; San Román J; Rebuelta M; Bermejo P; Buján J; Bellón JM; Honduvilla NG; Escudero C
    J Mater Sci Mater Med; 1999 Dec; 10(12):873-8. PubMed ID: 15347968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Single oral dose pharmacokinetics of the two main components of pristinamycin in humans.
    Koechlin C; Kempf JF; Jehl F; Monteil H
    J Antimicrob Chemother; 1990 Apr; 25(4):651-6. PubMed ID: 2112540
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of food on salsalate absorption.
    Harrison LI; Riedel DJ; Armstrong KE; Goldlust MB; Ekholm BP
    Ther Drug Monit; 1992 Apr; 14(2):87-91. PubMed ID: 1585407
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics, safety, and tolerability of flosequinan in patients with hepatic dysfunction.
    Hinson JL; Hind ID; Weidler DJ
    J Pharm Sci; 1994 Mar; 83(3):382-5. PubMed ID: 8207686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of nicotinic acid-salicylic acid interaction.
    Ding RW; Kolbe K; Merz B; de Vries J; Weber E; Benet LZ
    Clin Pharmacol Ther; 1989 Dec; 46(6):642-7. PubMed ID: 2598568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers.
    Hercelin B; Leroy P; Nicolas A; Gavriloff C; Chassard D; Thébault JJ; Reveillaud MT; Salles MF; Netter P
    Eur J Clin Pharmacol; 1992; 43(1):93-5. PubMed ID: 1505618
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nonlinear elimination of methyprylon (noludar) in an overdosed patient: correlation of clinical effects with plasma concentration.
    Contos DA; Dixon KF; Guthrie RM; Gerber N; Mays DC
    J Pharm Sci; 1991 Aug; 80(8):768-71. PubMed ID: 1686463
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blood and plasma concentrations of butalbital following single oral doses in man.
    Drost ML; Walter L
    J Anal Toxicol; 1988; 12(6):322-4. PubMed ID: 3244271
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.
    Brørs O; Jacobsen S
    Eur J Clin Pharmacol; 1979 May; 15(4):281-6. PubMed ID: 477713
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacokinetics of triflusal after single and repeated doses in man.
    Ramis J; Torrent J; Mis R; Conte L; Barbanoj MJ; Jané J; Forn J
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):344-9. PubMed ID: 2272716
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Photosensitivity to Triflusal: Formation of a Photoadduct with Ubiquitin Demonstrated by Photophysical and Proteomic Techniques.
    Nuin E; Pérez-Sala D; Lhiaubet-Vallet V; Andreu I; Miranda MA
    Front Pharmacol; 2016; 7():277. PubMed ID: 27621705
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Robust neuroprotective effects of 2-((2-oxopropanoyl)oxy)-4-(trifluoromethyl)benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain.
    Kim SW; Lee HK; Kim ID; Lee H; Luo L; Park JY; Yoon SH; Lee JK
    Sci Rep; 2016 Aug; 6():31843. PubMed ID: 27545301
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study.
    Park SM; Lee J; Seong SJ; Park JG; Gwon MR; Lim MS; Lee HW; Yoon YR; Yang DH; Kwon KI; Han S
    BMC Pharmacol Toxicol; 2014 Dec; 15():75. PubMed ID: 25534747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.